Trinity Biotech Plc
(NASDAQ) TRIB
Trinity Biotech Plc Financials at a Glance
Market Cap
$7.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$43.86M
Net Income (TTM)
-$37.43M
EPS (TTM)
-$1.76
P/E Ratio
-0.22
Dividend
$0.00
Beta (Volatility)
0.67 (Low)
Dividend
$0.00
Beta (Volatility)
0.67 (Low)
Price
$0.38
Volume
5,925
Open
$0.38
Price
$0.38
Volume
5,925
Open
$0.38
Previous Close
$0.38
Daily Range
$0.37 - $0.39
52-Week Range
$0.31 - $3.44
Estimated Earnings Date
Sep 3, 2026
Dividend
$0.00
Beta (Volatility)
0.67 (Low)
Price
$0.38
Volume
5,925
Open
$0.38
Previous Close
$0.38
Daily Range
$0.37 - $0.39
52-Week Range
$0.31 - $3.44
Estimated Earnings Date
Sep 3, 2026
TRIB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Trinity Biotech Plc
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
287
CEO
John Gillard
Website
www.trinitybiotech.comHeadquarters
Bray, WW A98 H5C8, IE
TRIB Financials
Key Financial Metrics (TTM)
Gross Margin
35.40%
Operating Margin
-25.66%
Net Income Margin
-85.32%
Return on Equity
68.09%
Return on Capital
-17.30%
Return on Assets
-35.59%
Earnings Yield
-4.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
19.34M
Volume
5.92K
Avg. Volume
1.30M
Financials (TTM)
Gross Profit
$15.53M
Operating Income
-$11.26M
EBITDA
-$8.57M
Operating Cash Flow
-$6.26M
Capital Expenditure
-$88.26K
Free Cash Flow
-$6.34M
Cash & ST Invst.
$5.14M
Total Debt
$137.98M
Trinity Biotech Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.06M
-30.2%
Gross Profit
$3.55M
-27.3%
Gross Margin
32.05%
N/A
Market Cap
$7.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$26.06K
N/A
Employees
287
N/A
Net Income
-$17.46M
-3.0%
EBITDA
-$2.21M
+76.9%
Quarterly Fundamentals
Total Cash
$5.14M
-0.6%
Total Debt
$137.98M
+36.9%
Accounts Receivable
$10.28M
-29.6%
Inventory
$18.83M
-2.8%
Long Term Debt
$27.17M
-72.4%
Short Term Debt
$110.81M
+4341.4%
Return on Assets
-35.59%
N/A
Return on Invested Capital
31.23%
N/A
Free Cash Flow
-$1.54M
-350.6%
Operating Cash Flow
-$1.55M
-146.3%